Abbott Laboratories (ABT) revealed earnings for its third quarter that increased from the same period last year and beat the Street estimates.
The company's earnings came in at $1.646 billion, or $0.94 per share. This compares with $1.436 billion, or $0.82 per share, in last year's third quarter.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.119 billion or $1.21 per share for the period.
Analysts on average had expected the company to earn $1.20 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 4.9% to $10.635 billion from $10.143 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings (Q3): $1.646 Bln. vs. $1.436 Bln. last year.-EPS (Q3): $0.94 vs. $0.82 last year.-Revenue (Q3): $10.635 Bln vs. $10.143 Bln last year.
-Guidance:Next quarter EPS guidance: $1.31 to $1.37Full year EPS guidance: $4.64 to $4.70
For comments and feedback contact: editorial@rttnews.com
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.